The protein eIF4A3 may hold the key for future cancer treatments, Karolinska researchers find.
Up To Date
Latest News
British drug developer Mission Therapeutics plc has bagged a $20m milestone payment from Abbvie within the...
The big pharma company is shelling out US$1.5bn in the acquisition of US screening specialist Vividion...
Belgian semiconductor specialist Spectricity BV has baged €14m to speed up the development of mobile...
Sanofi further launches into the messenger RNA space with US$3.2bn buy-out of mRNA pioneer Translate Bio.
Life sciences tool provider Abcam plc has entered into a definitive agreement to acquire BioVision, Inc. for...